Rapid and cost-effective development of stable clones for the production of anti-Ebola monoclonal antibodies in HEK293T cells
E. Gonzalez-Gonzalez, I. Palestino-Diaz, F. Lopez-Pacheco, A. R. Marquez-Ipiña, I. M. Lara-Mayorga, G. Trujillo-de Santiago, M. M. Alvarez
This paper describes a method to rapidly generate stable clones producing anti-Ebola monoclonal antibodies in HEK293T cells, achieving high expression levels within 10 weeks.
bioRxiv · Apr 21, 2020 · PreprintBioengineering